id | C00027935 |
---|---|
Name | beta-Yohimbine |
CAS RN | 549-84-8 |
Standard InChI | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18+,19+/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 229 |
By standard InChI | CHEMBL2079555 |
---|---|
By standard InChI Main Layer | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 CHEMBL465600 CHEMBL1327758 CHEMBL1472740 CHEMBL1473950 CHEMBL1475803 CHEMBL1514351 CHEMBL1526082 CHEMBL1531132 CHEMBL1625779 CHEMBL2079555 |
By LinkDB |
---|
By CAS RN |
---|
class name | count |
---|---|
asterids | 2 |
family name | count |
---|---|
Apocynaceae | 2 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Aspidosperma ramiflorum Muell.-Arg. | 84858 | Apocynaceae | asterids | Viridiplantae |
Haplophyton crooksii L.Benson | 141566 | Apocynaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 CHEMBL2079555 |
CHEMBL729201
(1)
CHEMBL729203
(1)
CHEMBL729204 (1) CHEMBL729205 (1) CHEMBL729206 (3) CHEMBL758056 (1) CHEMBL828928 (1) CHEMBL827154 (1) CHEMBL1614110 (11) CHEMBL1741321 (9) CHEMBL1909136 (2) |
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL15245 |
CHEMBL1613805
(1)
|
0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL31410 CHEMBL1531132 |
CHEMBL1738312
(2)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL15245 |
CHEMBL1794367
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL1794499
(3)
|
2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1738091
(1)
CHEMBL1738565
(1)
CHEMBL1909139 (2) |
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL15245 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL15245 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL15245 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL15245 |
CHEMBL881969
(1)
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL15245 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL15245 |
CHEMBL1909176
(2)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL1472740 |
CHEMBL1613818
(1)
|
6 / 4 |
P29466 | Caspase-1 | C14 | CHEMBL15245 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL15245 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL15245 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL15245 |
CHEMBL1909197
(2)
|
2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL15245 CHEMBL31410 CHEMBL1531132 |
CHEMBL1794585
(3)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL31410 CHEMBL1327758 |
CHEMBL1614544
(4)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL31410 CHEMBL1327758 |
CHEMBL1614281
(1)
CHEMBL1614361
(3)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL1472740 |
CHEMBL1613776
(1)
|
3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL15245 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL15245 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL15245 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL15245 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL15245 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648623 (3) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL829301 (1) CHEMBL1909090 (2) |
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909093
(2)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL15245 |
CHEMBL1908285
(1)
CHEMBL1908286
(1)
CHEMBL1908289 (1) CHEMBL1908291 (1) CHEMBL1908292 (1) |
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL15245 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL15245 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL15245 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1614027
(2)
CHEMBL1741325
(9)
CHEMBL1909135 (2) |
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL15245 |
CHEMBL1909203
(2)
|
1 / 11 |
P11387 | DNA topoisomerase 1 | Isomerase | CHEMBL15245 CHEMBL465600 |
CHEMBL1003401
(3)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1472740 |
CHEMBL1794311
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL15245 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL15245 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL15245 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL15245 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL15245 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL15245 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL15245 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909166
(2)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL31410 CHEMBL1472740 |
CHEMBL1614458
(2)
|
0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL31410 CHEMBL1531132 |
CHEMBL1794495
(2)
|
2 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL15245 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL31410 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL10347 CHEMBL31410 |
CHEMBL1794486
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL15245 |
CHEMBL1738606
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL31410 |
CHEMBL2114780
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL15245 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL647963 (1) CHEMBL647721 (3) CHEMBL647725 (1) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL839549 (1) CHEMBL972062 (1) CHEMBL1226896 (2) CHEMBL1227024 (1) CHEMBL1228582 (1) CHEMBL1228583 (1) CHEMBL1228584 (2) CHEMBL1909088 (2) |
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL15245 |
CHEMBL1909101
(2)
|
0 / 0 |
P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL647014
(1)
CHEMBL648807
(1)
CHEMBL647810 (2) CHEMBL647813 (1) CHEMBL647045 (3) CHEMBL772607 (1) CHEMBL815329 (1) CHEMBL840159 (1) |
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL15245 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL15245 |
CHEMBL850007
(1)
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL15245 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL15245 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL15245 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL15245 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL15245 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL15245 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL15245 |
CHEMBL1909119
(2)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL1531132 |
CHEMBL2114810
(1)
|
7 / 3 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1472740 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL15245 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL15245 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL15245 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL15245 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL15245 |
CHEMBL1909114
(2)
|
0 / 0 |
P30304 | M-phase inducer phosphatase 1 | Ser_Thr_Tyr | CHEMBL15245 |
CHEMBL2157130
(1)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL15245 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL15245 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL15245 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1741322
(9)
CHEMBL1909132
(2)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 |
CHEMBL1613910
(3)
|
3 / 3 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL15245 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL15245 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL15245 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL15245 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL15245 |
CHEMBL850007
(1)
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL15245 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL15245 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909168
(2)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL31410 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1472740 CHEMBL1514351 |
CHEMBL1614240
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1613777
(2)
CHEMBL1741323
(9)
CHEMBL1909134 (2) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1472740 CHEMBL1473950 CHEMBL1514351 |
CHEMBL1614108
(4)
CHEMBL1613886
(4)
CHEMBL1741324 (9) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL15245 |
CHEMBL1909137
(2)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL31410 CHEMBL1531132 |
CHEMBL1794483
(2)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL31410 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1327758 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1472740 CHEMBL1531132 |
CHEMBL1614250
(1)
CHEMBL1614421
(2)
|
4 / 3 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | CHEMBL10347 |
CHEMBL1061237
(1)
|
1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL15245 |
CHEMBL806826
(1)
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL646104
(3)
CHEMBL643573
(2)
CHEMBL647014 (1) CHEMBL648807 (1) CHEMBL647813 (1) CHEMBL772607 (1) CHEMBL1909087 (2) |
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL15245 |
CHEMBL1909213
(2)
|
0 / 0 |
P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL647014
(1)
CHEMBL648807
(1)
CHEMBL647813 (1) CHEMBL648098 (2) CHEMBL649156 (3) CHEMBL651996 (1) CHEMBL651997 (1) CHEMBL772607 (1) |
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL646117 (1) CHEMBL644759 (3) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL839550 (1) CHEMBL1909089 (2) |
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL15245 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL15245 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL15245 |
CHEMBL1909128
(2)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1327758 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1531132 |
CHEMBL1613914
(4)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL15245 CHEMBL31410 |
CHEMBL1738442
(2)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 CHEMBL1531132 |
CHEMBL1614257
(2)
CHEMBL1614531
(5)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 CHEMBL1531132 |
CHEMBL1614257
(2)
CHEMBL1614531
(5)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL1327758 CHEMBL1475803 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL1327758 CHEMBL1475803 |
CHEMBL1613933
(2)
|
1 / 6 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
2 / 2 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
3 / 2 |
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|